Market InstituteMarket Institute
  • About
    • Who We Are
  • Research & Commentary
    • Papers
  • Events
  • Issues
  • Projects
    • International Overreach: When Global Standards Become U.S. Policy
    • Alzheimer’s
    • Letters
    • Political Cartoons

Research & Commentary

Articles

Fairy tale populism and intellectual property theft

The U.S. International Trade Commission recently released a 500-page report Read more…

By admin, 2 years2 years ago
Articles

Would Lina Khan and the EU Have Blocked Amazon’s Acquistion?

Delve into the intriguing world of tech acquisitions and antitrust Read more…

By admin, 2 years2 years ago
Articles

Sanders’ Transparent Attempt to Bully Drug Companies

In a recent turn of events, Senator Bernie Sanders has Read more…

By admin, 2 years2 years ago
Articles

To Ban TikTok Is To Ban Individual American Freedom

In a new article at Real Clear Markets Norm Singleton, Read more…

By admin, 2 years2 years ago
Letter

Coalition: Reauthorize TCJA Provisions to Protect Taxpayers and Businesses

As we step into the dawn of a new year, Read more…

By admin, 2 years2 years ago
Articles

Do We Really Need a Republican Lina Khan?

Norm Singleton, Senior Fellow at the Market Institute, dissects the Read more…

By admin, 2 years2 years ago
Articles

Democratic Party Civil War: Abundance Economics vs. Lina Khanonomics

Amidst a charged Presidential race, the left is undergoing a Read more…

By admin, 2 years2 years ago
Articles

Big Labor Won’t Boost Its Appeal To Labor With Politics

In his new article, Norm Singleton, Senior Fellow at The Read more…

By admin, 2 years2 years ago
Articles

Jim Jordan Is Worried About the Right Policies, Antitrust Overreach In Particular

Ohio Representative and House Judiciary Committee Chair Jim Jordan’s distinctive Read more…

By admin, 2 years2 years ago
Articles

The Courts and Congress Must Protect Free Speech

In a new piece at Real Clear Markets, Market Institute Read more…

By admin, 2 years2 years ago

Posts pagination

Previous 1 … 21 22 23 … 37 Next
Recent Articles
  • Patents Play a Substantial Role In American Innovation June 4, 2026
  • Charles Sauer Discusses Medicare Advantage Reform on the Scott Sloan Show June 3, 2026
  • Section 232 Tariffs on Medical Devices are a Blunt Instrument for a Precision Industry June 3, 2026
  • Oz Cracks Down on Fraud. Medicare Advantage Next. May 31, 2026
  • Charles Sauer Discusses Alzheimer’s on the Lars Larson Show May 22, 2026
Recent Papers
  • The $135 Billion Lie: How Upcoding Is Draining Medicare and Medicaid
  • Why Does the Government Pay More for the Same Care?
  • The Practical, Constitutional, and Moral Case Against Social Media Regulation “For the Children”
  • Free Markets Under Attack from the Left and Right
  • A Free Market is a Fair Market

Loading

By adding your phone number, you opt in to receive text messages

Facebook
Twitter
YouTube

The Market Institute Follow

The Market Institute promotes the work of free market think tanks and associations. We Get Government Out of the Way.

MarketInstitute
Retweet on Twitter The Market Institute Retweeted
sayno2socialmed Coalition Against Socialized Medicine @sayno2socialmed ·
21h

Behind every breakthrough medicine is a patent system worth defending.

Today’s @JudiciaryGOP hearing made that case.

Failing to protect IP rights cedes America’s biotech edge to foreign competitors and leaves patients without access to the medicines they depend on.

Reply on Twitter 2062647581562327397 Retweet on Twitter 2062647581562327397 1 Like on Twitter 2062647581562327397 1 X 2062647581562327397
marketinstitute The Market Institute @marketinstitute ·
4 Jun

Patients don’t need Washington deciding what medical information they’re allowed to see.

DTC ads empower patients, spark doctor conversations, and help newer treatments compete.

Don’t keep patients in the dark.

Competitive Enterprise Institute @ceidotorg

Banning these advertisements outright - or regulating them into oblivion - would crush competition and keep patients in the dark. Consumers do not need
government bureaucrats gate-keeping medical information. CEI joins a coalition with @taxreformer, @AmerComm @CFEconomy

Reply on Twitter 2062592590201946407 Retweet on Twitter 2062592590201946407 Like on Twitter 2062592590201946407 X 2062592590201946407
marketinstitute The Market Institute @marketinstitute ·
4 Jun

PTAB was supposed to weed out bad patents.

Instead, it became a weapon for deep-pocketed corporations to attack innovators again and again. Hatch-Waxman already gives generic manufacturers a proven pathway to challenge patents and bring lower-cost medicines to market.

Serial

Reply on Twitter 2062565847835595228 Retweet on Twitter 2062565847835595228 Like on Twitter 2062565847835595228 X 2062565847835595228
Load More

  • About
  • Research & Commentary
  • Events
  • Issues
  • Projects